• 1
    Central Brain Tumor Registry of the United States (CBTRUS): 2010 tables. Available at: Accessed August 3, 2010.
  • 2
    Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 2001; 36: 549-556.
  • 3
    van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005; 366: 985-990.
  • 4
    Pignatti F, van den Bent MJ, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002; 20: 2076-2084.
  • 5
    Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence. SEER 17 Registries Research Data + Hurricane Katrina Impacted Louisiana Cases, November 2008 Submission (1973-2006 varying). Linked to County Attributes. Total U.S., 1969-2006 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Released April 2009. Available at: Accessed on March 30, 2010.
  • 6
    Halperin E, Perez C, Brady L. Principles and Practice of Radiation Oncology. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008.
  • 7
    Jenkins RB, Blair H, Ballman KV, et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 2006; 66: 9852-9861.
  • 8
    Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Cancer Central Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002; 20: 2267-2276.
  • 9
    Eyre HJ, Crowley JJ, Townsend JJ, et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg. 1993; 78: 909-914.
  • 10
    Shaw E, Daumas-Duport C, Scheithauer BW, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg. 1989; 70: 853-861.
  • 11
    Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997; 15: 1295-1301.
  • 12
    Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol. 1997; 15: 3129-3140.
  • 13
    Yeh S-A, Ho JT, Lui CC, et al. Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. Br J Radiol. 2005; 78: 230-235.
  • 14
    Pouratian N, Mut M, Jagannathan J, et al. Low-grade gliomas in older patients: a retrospective analysis of prognostic factors. J Neurooncol. 2008; 90: 341-350.
  • 15
    Durmaz R, Vural M, Isildi E, et al. Efficacy of prognostic factors on survival in patients with low grade glioma. Turk Neurosurg. 2008; 18: 336-344.
  • 16
    Schomas DA, Laack NN, Rao RD, et al. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol. 2009; 11: 437-445.
  • 17
    Chang EF, Clark A, Jensen RL, et al. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. J Neurosurg. 2009; 111: 203-210.
  • 18
    Bauman G, Fisher B, Watling C, et al. Adult supratentorial low-grade glioma: long-term experience at a single institution. Int J Radiat Oncol Biol Phys. 2009; 75: 1401-1407.
  • 19
    Capelle L, Oei P, Teoh H, et al. Retrospective review of prognostic factors, including 1p19q deletion, in low-grade oligodendrogliomas and a review of recent published works. J Med Imaging Radiat Oncol. 2009; 53: 305-309.
  • 20
    Soffietti R, Baumert BG, Bello L, et al. Guidelines on management of low-grade gliomas: report of an EFNS–EANO Task Force. Eur J Neurol. 2010; 17: 1124-1133.
  • 21
    Kaplan CP, Napoles AM, Hwang ES, et al. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health (Larchmt). 2011; 20: 215-223.
  • 22
    Martinez SR, Beal SH, Chen SL, et al. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2010; 78: 787-792.
  • 23
    Smith GL, Shih YC, Xu Y, et al. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer. 2010; 116: 734-741.
  • 24
    Yang R, Cheung MC, Byrne MM, et al. Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer. 2010; 116: 2437-2447.
  • 25
    Olson JD, Riedel E, DeAngelis LM, et al. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 2000; 54: 1442-1448.
  • 26
    Bartlett C, Doyal L, Ebrahim S, et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess. 2005; 9: 1-152.
  • 27
    Cottin V, Arpin D, Lasset C, et al. Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. Ann Oncol. 1999; 10: 809-815.
  • 28
    Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002; 162: 1682-1688.